Home
Why Syndax and Incyte Traded UP in Today’s Early Morning  

Why Syndax and Incyte Traded UP in Today’s Early Morning  

Today’s Highlights July 24, 2023

Syndax Pharmaceuticals and Incyte
Syndax Pharmaceuticals (SNDX) and Incyte (INCY) announced positive data from the pivotal AGAVE-201 trial of axatilimab, an anti-CSF-1R antibody, in adult and . . .

This content is for paid subscribers.
Please click here to subscribe or here to log in.
Today’s Highlights
,
July 24, 2023

Other Articles